Physician profile
Drew J Davis
NPI 1104006808
$5,790.04
in general payments reported to CMS, 2019-2025
22 companies · $1,053 in 2025
The $1,053 reported for 2025 was more than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $760 · 2020: $101 · 2021: $599 · 2022: $1,000 · 2023: $1,341 · 2024: $937 · 2025: $1,053.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,053 · Travel and Lodging: $278.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,053.31 |
| Travel and Lodging | $277.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sientra, INC. | $1,124.27 | 2019-2022 | |
| Abbvie INC. | $994.59 | 2023-2025 | Natrelle Saline-Filled Breast Implants |
| Tela Bio, INC. | $580.82 | 2022-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Mentor Worldwide LLC | $543.74 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Allergan, INC. | $531.42 | 2021-2022 | |
| Integra Lifesciences Corporation | $423.85 | 2023-2025 | Integra, Integra Dermal Regeneration Template, Durasorb Monofilament Mesh |
| Musculoskeletal Transplant Foundation INC. | $344.48 | 2023-2025 | |
| Motiva USA, LLC | $298.76 | 2024-2025 | |
| Galderma Laboratories, L.P. | $176.67 | 2019-2022 | |
| Innovation Technologies INC | $136.88 | 2024 | Irrisept |
| Revance Therapeutics, INC. | $106.85 | 2025 | Daxxify |
| Avita Medical Americas, LLC | $103.98 | 2024 | |
| Tei Biosciences INC | $97.80 | 2019 | |
| Davol INC. | $96.01 | 2023 | Phasix Mesh |
| Lifenet Health | $71.17 | 2025 | Theragenesis Wound Matrix |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz North America, INC. | $50.00 | 2021-2022 | |
| Pacira Pharmaceuticals Incorporated | $28.45 | 2025 | Exparel |
| Solta Medical, A Division of Bausch Health US, LLC | $20.64 | 2019 | |
| Zyla Life Sciences, INC. | $16.16 | 2020 | |
| Ethicon US, LLC | $14.97 | 2025 | Vistaseal, Echelon; Endopath |
| Smith+Nephew, INC. | $14.55 | 2019 | |
| Tepha INC | $13.98 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Drew Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.